PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Gaxilose→

Gaxilose PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
14087-31-1
Molecular formula
C11H20O10
Molecular weight
312.27 g/mol
Drug class
Diagnostic substratelactase activity test agent
Mechanism of action
Gaxilose (4-galactosylxylose) is an orally administered synthetic disaccharide substrate for intestinal lactase. Hydrolysis by lactase releases D-xylose and galactose; measurement of D-xylose in serum or urine provides an indirect assessment of intestinal lactase activity.
Indications / reported uses
  • Diagnostic assessment of intestinal lactase activity and lactose malabsorption using a serum or urine xylose measurement after oral administration, where the test is available and validated.

Sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC6839734/ · https://www.catlab.cat/uploads/20250115/CI139_ENG.pdf · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Gaxilose PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Gaxilose Permitted Daily Exposure (PDE) report (the Gaxilose PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Gaxilose Occupational Exposure Limit (OEL) report (the Gaxilose OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.